Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal ziconotide for refractory neuropathic pain in cancer patients
2008-005307-26Phase 2Completed
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Jun 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ziconotide in Neuralgia and cancer, sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Started Jun 2009; status: completed.
02
Drugs
ziconotide
03
Conditions
Neuralgiacancer
Beyond the preview
Go deeper on 2008-005307-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005307-26.